Clinical Presentation, Predictors, and Outcomes Among Mineralocorticoid Receptor Antagonist (MRA)-Eligible Acute Heart Failure Patients in the Heart Function Assessment Registry Trial in Saudi Arabia (HEARTS)

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Angiology

• Publication date

  2018-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/0003319717720051PMID 28750542
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TSOC-HFrEF Registry: A Registry of Hospitalized Patients with Decompensated Systolic Heart Failure: Description of Population and Management.

  2016cited by this paper
• Heart failure medications prescribed at discharge for patients with left ventricular assist devices.

  2016cited by this paper
• Adecuación en España a las recomendaciones terapéuticas de la guía de la ESC sobre insuficiencia cardiaca: ESC Heart Failure Long-term Registry

  2015cited by this paper
• Clinical presentation, management, in‐hospital and 90‐day outcomes of heart failure patients in Trivandrum, Kerala, India: the Trivandrum Heart Failure Registry

  2015cited by this paper
• Clinical features, management, and short‐ and long‐term outcomes of patients with acute decompensated heart failure: phase I results of the HEARTS database

  2014cited by this paper
• SUrvey of Guideline Adherence for Treatment of Systolic Heart Failure in Real World (SUGAR): A Multi-Center, Retrospective, Observational Study

  2014cited by this paper
• Assessment of guideline adherence in hospitalised heart failure patients with systolic dysfunction in Dubai, United Arab Emirates.

  2014cited by this paper
• Mineralocorticoid receptor antagonist use in eligible patients following acute myocardial infarction: real world data from the Acute Coronary Syndrome Israeli Surveys: 2004-2010.

  2013cited by this paper
• Use of aldosterone antagonists at discharge after myocardial infarction: results from the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network (ACTION) Registry-Get with the Guidelines (GWTG).

  2013cited by this paper
• Temporal trends and predictors in the use of aldosterone antagonists post-acute myocardial infarction.

  2013cited by this paper
• Transitional adherence and persistence in the use of aldosterone antagonist therapy in patients with heart failure.

  2013cited by this paper
• 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2013cited by this paper
• ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

  2012cited by this paper
• Associations between aldosterone antagonist therapy and risks of mortality and readmission among patients with heart failure and reduced ejection fraction.

  2012cited by this paper
• Is heart failure guideline adherence being underestimated? The impact of therapeutic contraindications.

  2012cited by this paper
• Treatment performance measures affect clinical outcomes in patients with acute systolic heart failure: report from the Korean Heart Failure Registry.

  2012cited by this paper
• The Romanian Acute Heart Failure Syndromes (RO-AHFS) registry.

  2011cited by this paper
• Design and preliminary results of the Heart Function Assessment Registry Trial in Saudi Arabia (HEARTS) in patients with acute and chronic heart failure †

  2011cited by this paper
• Eplerenone in patients with systolic heart failure and mild symptoms.

  2011cited by this paper
• SM-368229, a novel selective and potent non-steroidal mineralocorticoid receptor antagonist with strong urinary Na+ excretion activity.

  2011cited by this paper
• Improving Evidence-Based Care for Heart Failure in Outpatient Cardiology Practices: Primary Results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF)

  2010cited by this paper
• Acute decompensated heart failure syndromes (ATTEND) registry. A prospective observational multicenter cohort study: rationale, design, and preliminary data.

  2010cited by this paper
• Heart Failure Improving Evidence-Based Care for Heart Failure in Outpatient Cardiology Practices Primary Results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF)

  2010cited by this paper
• EURObservational Research Programme: The Heart Failure Pilot Survey (ESC‐HF Pilot)

  2010cited by this paper
• Use of aldosterone antagonists in heart failure.

  2009cited by this paper
• Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

  2009cited by this paper
• Understanding the ‘epidemic of heart failure’: a systematic review of trends in determinants of heart failure

  2009cited by this paper
• Heart Failure Care in the Outpatient Cardiology Practice Setting: Findings From IMPROVE HF

  2008cited by this paper
• ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 ‡

  2008cited by this paper
• 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

  2008cited by this paper
• EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population.

  2006cited by this paper
• Clinical profile, contemporary management and one‐year mortality in patients with severe acute heart failure syndromes: The EFICA study ☆

  2006cited by this paper
• Acute Heart Failure Syndromes: Current State and Framework for Future Research

  2005cited by this paper
• Nationwide survey on acute heart failure in cardiology ward services in Italy.

  2005cited by this paper
• ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction

  2004cited by this paper
• Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

  2003cited by this paper
• The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis.

  2003cited by this paper
• Aldosterone in congestive heart failure.

  2001cited by this paper
• The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

  1999cited by this paper

• A Saudi Heart Association Position Statement on Cardiovascular Diseases and Diabetes Mellitus

  2024influential citation
• A Saudi Heart Association Position Statement on Cardiovascular A Saudi Heart Association Position Statement on Cardiovascular Diseases and Diabetes Mellitus Diseases and Diabetes Mellitus

  year unknowninfluential citation